• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Search Results for: patent

Report Finds Average US Patent Cost US$ 374,000 In 2012

12/02/2013 by Intellectual Property Watch 2 Comments

A new quarterly report on patent sales by technology shows that in 2012 the median price paid for issued US patents was US$ 221,000, while the average price paid was US$ 374,000.

Filed Under: IP-Watch Briefs, IP Policies, Themes, Venues, English, Finance, Information and Communications Technology/ Broadcasting, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

Intellectual Ventures Sues Internet Providers For DSL Patent Infringement

12/02/2013 by Intellectual Property Watch 1 Comment

Intellectual Ventures, a patent holding company, has filed a patent infringement suit against DSL providers AT&T, CenturyLink and Windstream Communications.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, IP Law, Information and Communications Technology/ Broadcasting, North America, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer

Expiring GMO Patents Raise Regulatory Issues; Private Sector Takes Measures

05/02/2013 by Catherine Saez, Intellectual Property Watch 1 Comment

A number of patents on genetically modified organisms (GMOs) in agriculture will expire in the coming years and this could be a problem for the biotechnology industry in terms of regulatory authorisations. A private sector initiative has recently been launched to address the issue.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Access to Knowledge/ Education, Biodiversity/Genetic Resources/Biotech, English, Environment, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

EPO Sees Record Patent Filings, Grants

18/01/2013 by Intellectual Property Watch 1 Comment

The European Patent Office has announced that it reached new records in 2012 for patent filings and patents granted, according to preliminary figures. The United States remained at top, but growth was fastest in Asia, while European filings remained stable, it said.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Europe, Innovation/ R&D, Patents/Designs/Trade Secrets

Syngenta Opens Doors To Its Patented Technologies, For Easier But Not Free Access

18/01/2013 by Catherine Saez, Intellectual Property Watch 3 Comments

A new innovation platform launched yesterday by Syngenta, the international agri-business company, means to broaden availability to some patented traits and technologies for vegetables, but also aims at opening new ways to use the intellectual property system.

Filed Under: IP Policies, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Environment, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, United Nations - other

Company Takes A Fair Shot At Facebook, LinkedIn, With Social Networking Patents

15/01/2013 by William New, Intellectual Property Watch 3 Comments

A Virginia-based company in the midst of a multi-million dollar merger is asserting patents on fundamental aspects of social networking it says have been infringed by Facebook, LinkedIn and three other companies. But even if the patents have validity, they come at a time of what may be a backlash against such lawsuits.

Filed Under: Features, IP Policies, Themes, Venues, English, Finance, IP Law, Information and Communications Technology/ Broadcasting, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

US Issues Statement On Injunctions In Cases Of Standards Essential Patents

09/01/2013 by Intellectual Property Watch Leave a Comment

The United States Patent and Trademark Office and US Department of Justice yesterday issued a joint policy statement on standards essential patents that encourages voluntary technology licensing on fair, reasonable and non-discriminatory terms, and discourages injunctions or exclusionary orders that block infringing products from the market. Their advice to the International Trade Commission cites innovation, competition, consumers and the public interest.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Enforcement, English, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

Most-Read IP-Watch Stories Of 2012: India Pharma, Europe, ACTA, WIPO Technical Assistance, Gene Patents

30/12/2012 by William New, Intellectual Property Watch Leave a Comment

As 2012 becomes a memory, it is fair to say that the intellectual property rights discussion shifted over the past year, with trade agreements, over-reaching in copyright and patents, and the provision of technical assistance all falling under increased pressure. At least if the most-read Intellectual Property Watch stories of the year are any indication.

Filed Under: Features, IP Policies, Language, Venues, Bilateral/Regional Negotiations, Copyright Policy, English, Europe, North America, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, United Nations - other, WIPO, WTO/TRIPS

US Supreme Court Poised To Rule Human Genes Are Not Patentable

21/12/2012 by Steven Seidenberg for Intellectual Property Watch 2 Comments

For decades, the United States has pioneered the patenting of human genes, and other countries have followed this lead. But the US will soon perform an abrupt about-face, most experts predict. When the US Supreme Court hands down its decision in Association for Molecular Pathology v. Myriad Genetics, the justices appear likely to rule that human genes are not patentable subject matter. And the ruling may go even farther, holding that other forms of human DNA are not patentable.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Environment, Health & IP, Human Rights, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Perspectives on the US

European Unitary Patent And Court Becomes Reality

11/12/2012 by Dugie Standeford for Intellectual Property Watch 3 Comments

A years’-long struggle ended Tuesday when the European Parliament overwhelmingly backed the creation of a unitary EU patent and patent litigation court system. The vote followed Monday’s approval by the Council of Ministers. But hard feelings over a last-minute government compromise, and continuing concerns about whether the new regime will make patenting in Europe cheaper and more accessible to smaller enterprises, continued to rankle. The European Court of Justice (ECJ), meanwhile, appears headed toward rejection of a legal challenge by Italy and Spain, who have refused to join the unitary patent system.

Filed Under: IP Policies, Language, Themes, Venues, English, Europe, IP Law, Innovation/ R&D, Patents/Designs/Trade Secrets

  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 347
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2026 · Global Policy Reporting